FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Hospira Propofol Injectable Emulsion Recall

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged in 5 Units x 20 mL…

Hospira Inc. · Lake Forest, IL

Risk level
Class II
Reported by FDA
Sep 18, 2013
Recall ID
D-932-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Propofol Injectable Emulsion starting Aug 14, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-932-2013 on Sep 18, 2013. Reason: Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.

Product description

Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged in 5 Units x 20 mL Single patient infusion vials per carton, Rx only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-4699-30

Lot numbers, UPCs & expiration codes

Lot #: 24-461-DJ*, Exp 12/14; 26-543-DJ*, Exp 02/15; 27-555-DJ*, 27-559-DJ*, Exp 03/15; *lot number may be followed by 01

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-932-2013
Classification
Class II
Status
Terminated
Recall initiated
Aug 14, 2013
FDA report date
Sep 18, 2013
Quantity
283,150 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-932-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Terminated
Country
United States
Event ID
66134
Address
275 N Field Dr
Code information
Lot #: 24-461-DJ*, Exp 12/14; 26-543-DJ*, Exp 02/15; 27-555-DJ*, 27-559-DJ*, Exp 03/15; *lot number may be followed by 01
Postal code
60045-2579
Report date
Sep 18, 2013
Product type
Drugs
Recall number
D-932-2013
Classification
Class II
Recalling firm
Hospira Inc.
Product quantity
283,150 vials
Termination date
Sep 18, 2014
Reason for recall
Presence of Particulate Matter: Visible particulate embedded in the glass vial was observed and confirmed in a sample bottle during retain sample inspection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), packaged in 5 Units x 20 mL Single patient infusion vials per carton, Rx only, Hospira, Inc. Lake Forest, IL 60045, NDC 0409-4699-30
Distribution pattern
Nationwide
Recall initiation date
Aug 14, 2013
Initial firm notification
Letter
Center classification date
Sep 9, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-932-2013, published Sep 18, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls